Literature DB >> 20176213

In vivo monitoring of function of autologous engineered pulmonary valve.

Danielle Gottlieb1, Tandon Kunal, Sitaram Emani, Elena Aikawa, David W Brown, Andrew J Powell, Arthur Nedder, George C Engelmayr, Juan M Melero-Martin, Michael S Sacks, John E Mayer.   

Abstract

OBJECTIVES: Clinical translation of tissue-engineered heart valves requires valve competency and lack of stenosis in the short and long term. Early studies of engineered valves showed promise, although lacked complete definition of valve function. Building on prior experiments, we sought to define the in vivo changes in structure and function of autologous engineered pulmonary valved conduits.
METHODS: Mesenchymal stem cells were isolated from neonatal sheep bone marrow and seeded onto a bioresorbable scaffold. After 4 weeks of culture, valved conduits were implanted. Valve function, cusp, and conduit dimensions were evaluated at implantation (echocardiography), at the experimental midpoint (magnetic resonance imaging), and at explant, at 1 day, and 1, 6, 12, or 20 weeks postoperatively (direct measurement, echocardiography). Histologic evaluation was performed.
RESULTS: Nineteen animals underwent autologous tissue-engineered valved conduit replacement. At implantation, valved conduit function was excellent; maximum transvalvular pressure gradient by Doppler echocardiography was 17 mm Hg; most valved conduits showed trivial pulmonary regurgitation. At 6 postoperative weeks, valve cusps appeared less mobile; pulmonary regurgitation was mild to moderate. At 12 weeks or more, valved conduit cusps were increasingly attenuated and regurgitant. Valved conduit diameter remained unchanged over 20 weeks. Dimensional measurements by magnetic resonance imaging correlated with direct measurement at explant.
CONCLUSIONS: We demonstrate autologous engineered tissue valved conduits that function well at implantation, with subsequent monitoring of dimensions and function in real time by magnetic resonance imaging. In vivo valves undergo structural and functional remodeling without stenosis, but with worsening pulmonary regurgitation after 6 weeks. Insights into mechanisms of in vivo remodeling are valuable for future iterations of engineered heart valves. Copyright 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20176213     DOI: 10.1016/j.jtcvs.2009.11.006

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  43 in total

Review 1.  EMT-inducing biomaterials for heart valve engineering: taking cues from developmental biology.

Authors:  M K Sewell-Loftin; Young Wook Chun; Ali Khademhosseini; W David Merryman
Journal:  J Cardiovasc Transl Res       Date:  2011-07-13       Impact factor: 4.132

Review 2.  How to make a heart valve: from embryonic development to bioengineering of living valve substitutes.

Authors:  Donal MacGrogan; Guillermo Luxán; Anita Driessen-Mol; Carlijn Bouten; Frank Baaijens; José Luis de la Pompa
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

Review 3.  Heart Valve Replacements with Regenerative Capacity.

Authors:  Petra E Dijkman; Emanuela S Fioretta; Laura Frese; Francesco S Pasqualini; Simon P Hoerstrup
Journal:  Transfus Med Hemother       Date:  2016-07-26       Impact factor: 3.747

Review 4.  Bioengineered tissue solutions for repair, correction and reconstruction in cardiovascular surgery.

Authors:  Laura Iop; Tiziana Palmosi; Eleonora Dal Sasso; Gino Gerosa
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

5.  Pediatric tubular pulmonary heart valve from decellularized engineered tissue tubes.

Authors:  Jay M Reimer; Zeeshan H Syedain; Bee H T Haynie; Robert T Tranquillo
Journal:  Biomaterials       Date:  2015-05-16       Impact factor: 12.479

6.  Laser microfabricated poly(glycerol sebacate) scaffolds for heart valve tissue engineering.

Authors:  Nafiseh Masoumi; Aurélie Jean; Jeffrey T Zugates; Katherine L Johnson; George C Engelmayr
Journal:  J Biomed Mater Res A       Date:  2012-07-24       Impact factor: 4.396

7.  A mathematical model for the determination of forming tissue moduli in needled-nonwoven scaffolds.

Authors:  João S Soares; Will Zhang; Michael S Sacks
Journal:  Acta Biomater       Date:  2017-01-05       Impact factor: 8.947

8.  Electrospun PGS:PCL microfibers align human valvular interstitial cells and provide tunable scaffold anisotropy.

Authors:  Nafiseh Masoumi; Benjamin L Larson; Nasim Annabi; Mahshid Kharaziha; Behnam Zamanian; Kayle S Shapero; Alexander T Cubberley; Gulden Camci-Unal; Keefe B Manning; John E Mayer; Ali Khademhosseini
Journal:  Adv Healthc Mater       Date:  2014-01-22       Impact factor: 9.933

9.  A multilayered valve leaflet promotes cell-laden collagen type I production and aortic valve hemodynamics.

Authors:  Aline L Y Nachlas; Siyi Li; Benjamin W Streeter; Kenneth J De Jesus Morales; Fatiesa Sulejmani; David Immanuel Madukauwa-David; Donald Bejleri; Wei Sun; Ajit P Yoganathan; Michael E Davis
Journal:  Biomaterials       Date:  2020-02-12       Impact factor: 12.479

10.  Regional structural and biomechanical alterations of the ovine main pulmonary artery during postnatal growth.

Authors:  Bahar Fata; Christopher A Carruthers; Gregory Gibson; Simon C Watkins; Danielle Gottlieb; John E Mayer; Michael S Sacks
Journal:  J Biomech Eng       Date:  2013-02       Impact factor: 2.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.